Clinical trial
A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post…
NCT00135655 · Merck Sharp & Dohme LLC, Industry · Withdrawn
Key facts
| NCT number | NCT00135655 |
|---|---|
| Title | A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema |
| Official title | A Randomized, Double-Masked, Parallel, Group, Multi-Center, Dose Ranging Pilot Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Withdrawn |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Macular Edema, Cystoid |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) Intravitreal Injection |
| Enrollment | 0 |
| Start date | Aug 1, 2005 |
| First posted | Aug 26, 2005 |
| Last update posted | May 21, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: